Leukemia Clinical Trials

Showing 321-340 of 9,450 trials

Co-administration of CART22-65s and huCART19 for B-ALL

NCT05674175

This study will evaluate the safety and efficacy of administering two CAR T cell products, huCART19 and CART22-65s, in children with advanced B cell Acute Lymphoblastic Leukemia (B-ALL).

B-cell Acute Lymphoblastic LeukemiaB Lineage Lymphoblastic Lymphoma

Stephan Grupp MD PhD93 participantsStarted Jan 2023

Philadelphia, Pennsylvania, United States

Active Not RecruitingPhase 2

A Study of CPI-613 for Patients With Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-Grade B-Cell Lymphoma With High-Risk Translocations

NCT03793140

The purpose of this study is to test any good and bad effects of the study drug, CPI-613.

LymphomaLeukemia

Memorial Sloan Kettering Cancer Center24 participantsStarted Dec 2018

Duarte, California, United States • Boston, Massachusetts, United States • Basking Ridge, New Jersey, United States +8 more locations

Co-administration of CART22-65s and huCART19 for B-ALL

A Study of CPI-613 for Patients With Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-Grade B-Cell Lymphoma With High-Risk Translocations

Related Searches

Analysis of the Effectiveness and Safety of Lorlatinib in Untreated ALK-Positive NSCLC Patients in a French Real-World Context

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

A Trial of Trastuzumab Rezetecan in Unresectable Locally Recurrent/Metastatic Breast Cancer

Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Participants With High Risk Chronic Lymphocytic Leukemia (CLL)

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia

A Study to Evluate Efficacy and Safety of HRS-8080 Combined With Dalpiciclib in Patients With Advanced or Metastatic Breast Cancer Resistant to Adjuvant Endocrine Therapy.

CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)

Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Little NIRVANA for Pediatric Pain and Anxiety

Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda

Revumenib in Combination With 7+3 + Midostaurin in AML

VAG Versus Standard Chemotherapy With FLT3 Inhibitor in Adult Patients With FLT3-Mutated AML

Neoadjuvant Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

Gut Microbiome-Metabolome Profiling in H. Pylori-SIBO Comorbidity

A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)

MB-CART19.1 in Relapsed/Refractory Acute Lymphoblastic Leukemia

Clinico-biological Characterization and Survival of Patients With Adult T-cell Leukemia / Lymphoma (ATL) and Patients Chronically Infected With the HTLV-1 Virus (HTLV-OBS)